LXFR LUXFER HOLDINGS PLC
Industrial Inorganic Chemicals · NYSE · SEC CIK 1096056 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-1.9%
TTM net income YoY-58.2%
TTM EPS YoY-58.8%
Revenue 3-yr CAGR-3.2%
Net income 3-yr CAGR-34.1%
Margins
Gross margin23.2%
Operating margin6.2%
Net margin2.0%
FCF margin6.8%
EBITDA margin8.8%
Returns
ROE3.5%
ROA2.0%
ROIC (approx.)5.5%
Asset turnover1.02x
Leverage & solvency
Liabilities / assets38.8%
Debt / equity0.17x
Current ratio1.67x
Interest coverage7.74x
Cash quality & payout
Operating cash flow / net income4.42x
Accruals ratio-7.0%
Payout ratio180.5%
Capex / revenue2.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-27 | 2026Q22026-06-28 | 2026Q12026-03-29 | 2025Q4*2025-12-31 | 2025Q32025-09-28 | 2025Q22025-06-29 | 2025Q2*2025-06-28 | 2025Q12025-03-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $91.70M | $95.70M | $83.90M | $90.70M | $95.60M | $106.60M | $108.10M | $97.00M |
| Cost of revenue | $69.30M | $71.20M | $62.00M | $68.60M | $72.80M | $81.90M | — | $75.60M |
| Gross profit | $22.40M | $24.50M | $21.90M | $22.10M | $22.80M | $24.70M | — | $21.40M |
| R&D expense | $1.40M | $1.60M | $1.40M | $1.20M | $900,000 | $1.10M | — | $1.10M |
| SG&A expense | $11.80M | $12.30M | $11.40M | $12.60M | $11.80M | $13.50M | — | $12.60M |
| Operating income | $2.80M | $7.80M | $6.20M | $3.30M | $5.60M | $5.20M | — | $7.60M |
| Interest expense | $1.00M | $1.00M | $700,000 | $700,000 | $700,000 | $900,000 | — | $800,000 |
| Pretax income | $1.70M | $6.70M | $5.50M | $4.40M | $5.50M | $4.90M | — | $7.40M |
| Income tax | $800,000 | $1.90M | $1.70M | $2.00M | $2.80M | $2.30M | — | $1.90M |
| Net income | $900,000 | $4.80M | $3.60M | -$3.10M | $2.70M | $2.60M | — | $5.50M |
| EBITDA | $4.80M | $9.80M | $8.30M | $6.30M | $8.20M | $7.70M | — | $9.80M |
| EPS (basic) | 0.03 | 0.18 | 0.14 | — | 0.10 | 0.10 | — | 0.21 |
| EPS (diluted) | 0.03 | 0.18 | 0.13 | — | 0.10 | 0.10 | — | 0.20 |
| Dividends declared per share | — | — | — | — | — | — | — | 0.13 |
| Weighted avg. shares (diluted) | 27.30M | 27.22M | 26.80M | — | 27.16M | 27.10M | — | 27.13M |
| Balance sheet | ||||||||
| Cash & equivalents | $19.90M | $11.50M | $14.80M | $8.30M | $6.00M | $4.40M | — | $4.10M |
| Receivables | $62.70M | $65.00M | $59.30M | $50.00M | $48.90M | $55.10M | — | $51.40M |
| Inventory | $98.90M | $101.90M | $100.80M | $92.40M | $95.10M | $91.50M | — | $86.40M |
| Current assets | $191.00M | $185.80M | $188.20M | $164.00M | $167.30M | $183.60M | — | $175.70M |
| PP&E, net | $61.30M | $60.00M | $59.80M | $60.20M | $58.80M | $63.00M | — | $62.90M |
| Goodwill | $68.80M | $68.80M | $69.20M | $69.60M | $69.20M | $70.40M | — | $68.10M |
| Intangibles | $10.30M | $10.50M | $10.70M | $10.90M | $11.10M | $11.40M | — | $11.40M |
| Total assets | $383.30M | $389.00M | $392.40M | $369.70M | $377.40M | $399.20M | — | $385.20M |
| Current liabilities | $77.30M | $79.60M | $107.50M | $98.20M | $101.00M | $111.00M | — | $87.00M |
| Short-term debt | $0 | $0 | $25.00M | $25.00M | $25.00M | $28.70M | — | $1.10M |
| Long-term debt | $57.70M | $58.30M | $32.70M | $14.40M | $18.30M | $23.90M | — | $44.90M |
| Total debt | $57.70M | $58.30M | $57.70M | $39.40M | $43.30M | $52.60M | — | $46.00M |
| Total liabilities | $161.40M | $166.30M | $168.90M | $143.30M | $145.80M | $161.50M | — | $158.50M |
| Shareholders' equity | $221.90M | $222.70M | $223.50M | $226.40M | $231.60M | $237.70M | — | $226.70M |
| Net debt | $37.80M | $46.80M | $42.90M | $31.10M | $37.30M | $48.20M | — | $41.90M |
| Shares outstanding | 26.76M | 26.76M | 26.75M | 26.64M | 26.72M | 26.76M | — | 26.77M |
| Cash flow statement | ||||||||
| Operating cash flow | $15.60M | $2.70M | -$4.10M | $15.60M | $11.60M | $1.20M | — | $5.40M |
| Capital expenditure | $3.20M | $2.70M | $2.00M | $3.20M | $1.50M | $1.90M | — | $1.20M |
| Free cash flow | $12.40M | $0 | -$6.10M | $12.40M | $10.10M | -$700,000 | — | $4.20M |
| Investing cash flow | -$3.20M | -$2.60M | -$2.10M | -$4.80M | $3.00M | -$1.90M | — | -$1.40M |
| Financing cash flow | -$4.00M | -$3.40M | $12.60M | -$8.80M | -$13.00M | $1.00M | — | -$4.20M |
| Depreciation & amortization | $2.00M | $2.00M | $2.10M | $3.00M | $2.60M | $2.50M | — | $2.20M |
| Stock-based compensation | $900,000 | $1.20M | $1.10M | $800,000 | $1.00M | $900,000 | — | $900,000 |
| Dividends paid | $3.40M | $3.40M | $3.50M | $3.40M | $3.50M | $3.50M | — | $3.50M |
| Share buybacks | $0 | $700,000 | $700,000 | $1.20M | $800,000 | $600,000 | — | $500,000 |
Free plan shows the latest 8 periods; Pro shows all 50 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.